A Biomarker for Multiple Sclerosis
11/06/2015![[Translate to Englisch:] Professorin Stefanie Kürten und ihr Mitarbeiter Damiano Rovituso. (Foto: Robert Emmerich)](/fileadmin/_processed_/0/5/csm_kuerten1SPEZIAL_9c95fb13f6.jpg)
Patients with multiple sclerosis often receive a "hit and miss" treatment when the disease breaks out. A blood analysis is now for the first time able to reveal which of the two most important first-line drugs is better suited for which patients.
more